AIM WINNERS & LOSERS: Tialis Essential IT wins contract expansion deal
(Alliance News) - The following stocks are the leading risers and fallers on AIM on Tuesday. Read More
Price | 0.0425p on 02-09-2025 | at 15:12:06
---|---|
Change | 0.005p 13.33% |
Buy | 0.045p |
Sell | 0.04p |
Last Trade: | Sell 5,931,071.00 at 0.042p |
Day's Volume: | 707,861,013 |
Last Close: | 0.0375p |
Open: | 0.0475p |
ISIN: | GB0008854563 |
Day's Range | 0.0425p - 0.055p |
52wk Range: | 0.0285p - 0.0925p |
Market Capitalisation: | £2.11m |
VWAP: | 0.048791p |
Shares in Issue: | 4.96b |
Sector: Industrial Metals
Listed In: FTSE AIM All-Share,
Tertiary Minerals (TYM) Latest Trades |
||||
Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
---|---|---|---|---|
Sell* | 5,931,071 | 0.042p | Ordinary |
16:12:05 - 02-Sep-25 |
Buy* | 7,333 | 0.0435p | Ordinary |
16:05:33 - 02-Sep-25 |
Sell* | 1,956,798 | 0.0405p | Ordinary |
16:01:18 - 02-Sep-25 |
Sell* | 1,904,761 | 0.042p | Ordinary |
15:55:39 - 02-Sep-25 |
Buy* | 2,298 | 0.0435p | Ordinary |
15:51:45 - 02-Sep-25 |
Sell* | 810,927 | 0.0405p | Ordinary |
15:49:10 - 02-Sep-25 |
Sell* | 540,000 | 0.0405p | Ordinary |
15:41:09 - 02-Sep-25 |
Sell* | 235,849 | 0.0424p | Ordinary |
15:37:34 - 02-Sep-25 |
Sell* | 1,651,839 | 0.0405p | Ordinary |
15:13:49 - 02-Sep-25 |
Sell* | 2,918,579 | 0.0405p | Ordinary |
15:01:48 - 02-Sep-25 |
Tertiary Minerals (TYM) Regulatory News |
||
Date | Source | Headline |
---|---|---|
11th Aug 2025 7:00 am | RNS | Completion of Phase 2 at Target A1 - Mushima North |
31st Jul 2025 1:42 pm | RNS | Total Voting Rights |
25th Jul 2025 10:09 am | RNS | Holding(s) in Company |
25th Jul 2025 8:30 am | RNS | Holding(s) in Company |
21st Jul 2025 7:00 am | RNS | Drilling Commences at Target A1 - Mushima North |
8th Jul 2025 7:00 am | RNS | Upcoming Drill Programme - Mushima North, Zambia |
4th Jul 2025 9:45 am | RNS | Holding(s) in Company |
1st Jul 2025 11:31 am | RNS | Directors’ Subscriptions |
30th Jun 2025 10:13 am | RNS | Total Voting Rights |
27th Jun 2025 2:00 pm | RNS | Half-Yearly Report 2025 |